Metabolic Syndrome in Childhood Cancer Survivors
儿童癌症幸存者的代谢综合征
基本信息
- 批准号:7780049
- 负责人:
- 金额:$ 49.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2012-02-28
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAcute Lymphocytic LeukemiaAddressAdolescentAdultAdverse effectsAgeAntineoplastic AgentsBlood PressureBlood VesselsC-reactive proteinCancer SurvivorCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCarotid ArteriesCentral obesityChildCholesterolClinicalClinical ResearchComplexCranial IrradiationDataDemographic AgingDevelopmentDiabetes MellitusDiagnosisDietDietary AssessmentDietary FiberDietary PracticesDiseaseDoctor of PhilosophyDoseDyslipidemiasEndocrineEpidemiologic StudiesExposure toFastingFatty acid glycerol estersFiberFoodFrequenciesFundingFutureGenderGeneral PopulationGlucoseHealth behaviorHeartHematologic NeoplasmsHematopoietic Stem Cell TransplantationHormonalHormonesHourHyperinsulinismHypertensionImpairmentIndividualInflammation MediatorsInsulinInsulin ResistanceIntakeInterleukin-6InterventionIntervention TrialLengthLeptinLifeLipidsLiteratureLong-Term EffectsLong-Term SurvivorsMalignant Childhood NeoplasmMalignant NeoplasmsMalignant neoplasm of testisMeasurementMeasuresMeatMediatingMediator of activation proteinMetabolic syndromeMinnesotaNational Health and Nutrition Examination SurveyNon-Insulin-Dependent Diabetes MellitusNutrientObesityPathogenesisPathway interactionsPhysical activityPlayPopulationPopulation ControlPrevalencePreventive InterventionPrincipal InvestigatorRadiationRegimenReportingResearchResearch PersonnelRiskRisk FactorsRoleSamplingScheduleSerumSiblingsSliceSomatotropinSteroidsSurvivorsSyndromeTherapeuticThickTreatment ProtocolsTumor Necrosis Factor-alphaTumor Necrosis FactorsUniversitiesVasodilationVisceralX-Ray Computed Tomographyadipokinesadiponectinbrachial arterycancer therapycardiovascular disorder preventioncardiovascular risk factorchemotherapeutic agentchemotherapychildhood cancer survivordesignfollow-upgenetic analysisgrowth hormone deficiencyhigh riskhypothalamic pituitary axisinsightintima medialifestyle factorslow density lipoprotein triglyceridemortalityprematureprogramsresearch clinical testingsaturated fatsextv watching
项目摘要
As many individuals once treated for childhood cancer progress into adulthood, clinical and epidemiologic research is now focusing on an array of long-term effects from cancer treatment to characterize and understand the "consequences of cure". There is evidence to indicate that childhood cancer survivors (CCS) are at increased risk for the metabolic syndrome (MS). The syndrome is composed of obesity, insulin resistance, dyslipidemia and hypertension, and is a predictor of type 2 diabetes and cardiovascular disease. In healthy populations obesity has a central role in the development of the MS, however, it is conceivable that in CCS additional mechanisms other than obesity (e.g. endocrine abnormalities, exposure to radiation and antineoplastic agents) may play a critical role in the development of MS. The major objective of this proposal is to evaluate the relation between insulin resistance (by euglycemic insulin clamp), growth hormone deficiency and other mediators of insulin resistance, with the development of MS and cardiovascular risk early in life, before the relations between the components become complex and disease develops. We propose to study a sample of children and adolescents age 9-18 years, who survived childhood cancer for >5 years after diagnosis, and their healthy siblings, who will participate in a 2 day clinical evaluation. Specific aims are: 1) to determine the prevalence of MS in CCS and compare to healthy controls similar in age and gender distribution, 2) to assess the association of insulin resistance with other components of MS and with early signs of cardiovascular changes, and 3) to assess the relation between obesity and insulin resistance with growth hormone secretion,^adipokines and inflammatory mediators; 4) to evaluate health behaviors related to prevention of cardiovascular disease, diabetes, and obesity. This proposal addresses the need for clinical research focused on newly identified adverse effects of childhood cancer and its treatment, particularly for preventable/modifiable conditions, and will provide new data on potential etiologic factors and avenues for intervention.
由于许多人曾经接受过儿童癌症的治疗,因此临床和流行病学研究的进展,现在关注从癌症治疗中的一系列长期影响,以表征和理解“治愈的后果”。有证据表明,儿童癌症幸存者(CC)的代谢综合征(MS)的风险增加。该综合征由肥胖,胰岛素抵抗,血脂异常和高血压组成,是2型糖尿病和心血管疾病的预测指标。在健康人群中,肥胖在MS的发展中具有核心作用,但是,可以想象,在CCS中,肥胖以外的其他机制(例如内分泌异常,暴露于辐射和抗肿瘤剂)可能在MS发育中起关键作用。该提案的主要目的是评估胰岛素抵抗(通过葡萄糖胰岛素夹),生长激素缺乏症和其他胰岛素抵抗性介体之间的关系,以及在成分之间的关系早期生命的早期,MS和心血管风险的发展就变得复杂,并且疾病变得复杂。我们建议研究9-18岁儿童和青少年的样本,他们在诊断后的儿童癌症中生存了5年,以及他们的健康兄弟姐妹,他们将参加为期2天的临床评估。具体目的是:1)确定MS在CC中的普遍性并与年龄和性别分布相似的健康控制率相比,2)评估胰岛素抵抗与其他MS的其他成分的关联以及心血管变化的早期迹象,以及3)以评估肥胖和胰岛素抵抗与生长荷尔蒙分泌者之间的关系^) 4)评估与预防心血管疾病,糖尿病和肥胖有关的健康行为。该提案解决了针对新确定的儿童癌症及其治疗的新发现的临床研究的需求,特别是对于可预防/可修改的条件,并将提供有关潜在病因学因素和干预途径的新数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julia Steinberger其他文献
Julia Steinberger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julia Steinberger', 18)}}的其他基金
METABOLIC SYNDROME FOLLOWING TRANSPLANT FOR LEUKEMIA
白血病移植后的代谢综合征
- 批准号:
7951675 - 财政年份:2008
- 资助金额:
$ 49.82万 - 项目类别:
METABOLIC SYNDROME IN CHILDHOOD CANCER SURVIVORS
儿童癌症幸存者的代谢综合征
- 批准号:
7951674 - 财政年份:2008
- 资助金额:
$ 49.82万 - 项目类别:
CARDIOVASCULAR RISK AND INSULIN RESISTANCE: AGES 7-40
心血管风险和胰岛素抵抗:7-40 岁
- 批准号:
7951720 - 财政年份:2008
- 资助金额:
$ 49.82万 - 项目类别:
Cardiovascular Risk and Insulin Resistance: Age 7-40
心血管风险和胰岛素抵抗:7-40 岁
- 批准号:
7212019 - 财政年份:2007
- 资助金额:
$ 49.82万 - 项目类别:
Cardiovascular Risk and Insulin Resistance: Age 7-40
心血管风险和胰岛素抵抗:7-40 岁
- 批准号:
7426842 - 财政年份:2007
- 资助金额:
$ 49.82万 - 项目类别:
Cardiovascular Risk and Insulin Resistance: Age 7-40
心血管风险和胰岛素抵抗:7-40 岁
- 批准号:
8109215 - 财政年份:2007
- 资助金额:
$ 49.82万 - 项目类别:
Cardiovascular Risk and Insulin Resistance: Age 7-40
心血管风险和胰岛素抵抗:7-40 岁
- 批准号:
7650119 - 财政年份:2007
- 资助金额:
$ 49.82万 - 项目类别:
Metabolic Syndrome Following Transplant for Leukemia
白血病移植后的代谢综合征
- 批准号:
7470109 - 财政年份:2006
- 资助金额:
$ 49.82万 - 项目类别:
Metabolic Syndrome in Childhood Cancer Survivors
儿童癌症幸存者的代谢综合征
- 批准号:
7599705 - 财政年份:2006
- 资助金额:
$ 49.82万 - 项目类别:
Metabolic Syndrome in Childhood Cancer Survivors
儿童癌症幸存者的代谢综合征
- 批准号:
7216767 - 财政年份:2006
- 资助金额:
$ 49.82万 - 项目类别:
相似国自然基金
RBMX通过m6A依赖性相分离调控急性T淋巴细胞白血病发生发展的作用及机制研究
- 批准号:82300189
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
解析急性淋巴细胞白血病染色质可及性异常导致其糖皮质激素耐药的底层分子机制
- 批准号:82270155
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
基因工程敲减IL-6/CD40L的CAR-T细胞在复发/难治性急性B淋巴细胞白血病治疗中提高安全性的机制研究
- 批准号:82200249
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
解析急性淋巴细胞白血病染色质可及性异常导致其糖皮质激素耐药的底层分子机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基因工程敲减IL-6/CD40L的CAR-T细胞在复发/难治性急性B淋巴细胞白血病治疗中提高安全性的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
NanoOptogenetic immunotherapy for B cell lymphoma
B细胞淋巴瘤的纳米光遗传学免疫疗法
- 批准号:
10400658 - 财政年份:2019
- 资助金额:
$ 49.82万 - 项目类别:
NanoOptogenetic immunotherapy for B cell lymphoma
B细胞淋巴瘤的纳米光遗传学免疫疗法
- 批准号:
10665550 - 财政年份:2019
- 资助金额:
$ 49.82万 - 项目类别:
NanoOptogenetic immunotherapy for B cell lymphoma
B细胞淋巴瘤的纳米光遗传学免疫疗法
- 批准号:
9884744 - 财政年份:2019
- 资助金额:
$ 49.82万 - 项目类别:
Interfollicular epidermal stem cells in human and mouse skin
人和小鼠皮肤中的滤泡间表皮干细胞
- 批准号:
8149973 - 财政年份:2010
- 资助金额:
$ 49.82万 - 项目类别: